Sevelamer Carbonate
Product Images NDC 10135-660
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 10135-660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 3. Percentage Of Patients (y-axis) Attaining A Phosphorus Reduction From Baseline (mg/dl) At Least As Great As The Value Of The X-axis. (Sevelamer Carbonate 02)
Figure 4. Mean Phosphorus Change From Baseline For Patients Who Completed 52 Weeks Of Treatment (Sevelamer Carbonate 03)
Principal Display Panelndc 10135-0660-68sevelamer Carbonatetablets800 mg270 Tabletsrx Only (Sevelamer Carbonate 04)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.